
    
      PROTOCOL OUTLINE: Patients receive high dose cyclophosphamide IV on days 1-4. Beginning on
      day 10, patients receive filgrastim (G-CSF) until the absolute neutrophil count is greater
      than 1,000/mm3 for 2 consecutive days.

      Patients are followed every 3 months for at least 2 years and annually thereafter.
    
  